Thioridazine (sold under the brand names Mellaril or Melleril) is a first-generation antipsychotic drug belonging to the phenothiazine drug group and was previously widely used in the treatment of schizophrenia and psychosis. The branded product was withdrawn worldwide in 2005 because it caused severe cardiac arrhythmias. However, generic versions are still available in the United States.
via Wikipedia infobox
via PubMed
{{Infobox drug | verifiedrevid = 470608946 | IUPAC_name = 10-{2-[(RS)-1-Methylpiperidin-2-yl]ethyl}-2-methylsulfanylphenothiazine | image = Thioridazine.svg | image_class = skin-invert-image | width = 200px | image2 = Thioridazine ball-and-stick model from xtal 1975.png | image_class2 = bg-transparent | width2 = 250px
| Drugs.com = | MedlinePlus = a682119 | DailyMedID = Thioridazine | licence_US = Thioridazine | pregnancy_AU = C | pregnancy_US = N | legal_AU = | legal_BR = C1 | legal_BR_comment = | legal_CA = | legal_DE = | legal_NZ = | legal_UK = | legal_US = | legal_EU = | legal_UN = | legal_status = Withdrawn by the manufacturer worldwide; generic formulations are still available by prescription | routes_of_administration = Oral | class = Typical antipsychotic
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).